SITC Resource Library

On November 3, 2022, leading experts from the SITC Lung Cancer and Mesothelioma Immunotherapy Guideline Expert Panel presented "Case Studies in Immunotherapy for the Treatment of Lung Cancer and Mesothelioma – SITC CPG Webinar." This high-level webinar included case studies that illustrated execution of the Clinical Practice Guideline (CPG). The recorded webinar and presentation slides will be available shortly.

Webinar Faculty:

• Moderator: Roy S. Herbst, MD, PhD – Yale Cancer Center (Expert Panel Chair)
• Charu Aggarwal, MD, MPH – Perelman School of Medicine, University of Pennsylvania (Expert Panel Member)
• Patrick Forde, MBBCh – Johns Hopkins Medicine (Expert Panel Member)
• Fred R. Hirsch, MD, PhD – Mount Sinai Medical Center (Expert Panel Member)

The webinar discussed:

• Plan immunotherapy treatment regimens for challenging patient populations
• Identify management strategies for uncommon and/or atypically responsive toxicities
• Select appropriate treatment strategies for patients with relapsed and/or unresponsive disease
• Articulate the potential risks and benefits for proceeding with any other possible interventions specific to a given disease setting in the context of an immunotherapy treatment plan

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, please visit connected.sitcancer.org, or check out our free CPG mobile app.

The Practical Management Pearls and Case Studies Webinars are part of the Cancer Immunotherapy Clinical Practice Guidelines Advanced Webinar Series supported, in part, by grants from Amgen and Merck & Co., Inc. (as of 9/15/2021).

The SITC Clinical Practice Guidelines are produced by SITC and have no funding from outside sources.